From mild to severe symptoms – why we need personalised medicine to treat post-acute infection syndromes (PAISs)

Dr med. Dipl.-Psych. Lucas Adam is a graduate psychologist and an assistant physician at the Charité’s department of neurology and was a research fellow at the Max Planck Institute for Human Development, Berlin, and at Yale Medical School, USA. As a research assistant in the Franke working group, he is involved in conducting interventional and observational studies in the field of PAISs at the Charité’s department of neurology. Beyond that, his research activities focus on the relationship between stress and the immune system and its effects on mental and physical health. 

PD Dr med. Christiana Franke is a senior consultant at the department of neurology of the Charité hospital in Berlin and leads the neurological consultation hours on post COVID-19 and PAISs at the Campus Benjamin Franklin. Her main research areas are cognitive disorders and neurodegeneration. Dr Franke leads as a principal investigator the “PoCoVIT” trial funded by the Federal Ministry of Research, Technology and Space, which examines the effect of methylprednisolone in patients with cognitive deficits in the context of post COVID-19 syndrome, and is a project member of the “PAIS-Care” research project, which is funded by the Federal Ministry of Health. Her previous work contributes to broadening our understanding of the pathophysiological mechanisms of the post COVID-19 syndrome.